- Benchmark ASINB0FQKSWJN1
- MarketplaceUS
- Category ID702372011
- Analyzed Products
- Keywordskin care tools
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-27
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不适合进入。 现在看到的不是“新机会”，而是一个被强品牌主导、差异化不足、失败样本已经出现的类目；对大品牌来说也只是勉强能打，对小品牌来说没有现实的正面入口。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing结论很直接：这不是一个适合现在进入的市场。 用户预算50万CNY表面上能覆盖单个ASIN的前期启动，但这类市场已经明显被大品牌主导，且新进入产品的成功高度依赖品牌力与高投入，不适合小品牌硬闯。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):50.00%Which new brands have these successful new listings?Alternatives- 品牌/超市自有品牌止汗露：如 Dove、Degree、Mitchum、Arm & Hammer 等基础款，通常更便宜、购买更方便，且对大多数用户已足够用。
- 旅行装/迷你装普通止汗剂：先用低价小规格试用，成本更低，适合不确定是否需要临床强度的人群。
- 止汗喷雾或滚珠替代固体：如果用户介意白痕、涂抹感或觉得固体不顺手，喷雾/滚珠往往更容易上手且更快干。
- 无香型基础除臭剂（非临床强度）：对主要是体味而非重度出汗的用户，基础除臭剂通常更便宜，也更容易接受。
- 衣物腋下防汗贴/护垫：对于偶发性出汗或想避免衣物汗渍的人，这是低成本、低刺激的外部替代方案，不必更换身体护理产品。
- 处方强度止汗方案的线下替代：若是严重多汗，先咨询皮肤科使用处方级止汗产品，可能比反复购买高价临床款更有效。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入。 目前看到的信号非常清楚：只有 1 个可判断的新品牌样本，盈利/亏损各 50%，但真正能赚钱的只有老牌 Secret 的爆款 ASIN B0FQKSWJN1，它靠品牌力、基于旧款升级、功能差异化拿到 28.3% 利润率和约 16,670 美元月销；而另一个新上架 ASIN B0FL5ZJ5QW 直接失败，说明这个类目不是给普通新手做的。
Least investment in new productsNew products with Highest revenueMost investment in new productsSecret
Recent Monthly Revenue (USD):$16,670.00(1000pcs/month)B0FQKSWJN1 (4.7/5 (6146 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0FQKSWJN1 (4.7/5 (6146 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0FL5ZJ5QWBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场可以直接判死刑：不适合进入。 目前样本里只有2个新产品，盈利和亏损各1个，表面上是50%成功率，但真正能复制的只有一个盈利款，而且它是强品牌驱动的老listing延伸，不是普通小卖家可直接照搬的模型。
证据很明确：盈利款B0FQKSWJN1来自Secret，售价16.67美元，月销1000件，月营收16670美元，利润率28.3%，但已有6146条评论，早期投入7388.48美元，带有明显品牌力和旧链接承接特征；亏损款B0FL5ZJ5QW同样来自Secret，却是同品牌的新产品失败样本，说明这个类目里连大牌新推也不是稳定赚钱。 新品利润分布里，已知利润的样本只有2个，全部都落在20%~30%区间，没有任何15%以下的健康新入口，也没有高利润扩张空间；同时时间趋势显示2025年只有1个赚钱新品、1个亏钱新品，近几个月没有形成持续增长，市场不是在扩张，而是被少量品牌试水。最关键的是，这个可见成功案例是Secret这类老品牌/强品牌在推新，不能算小卖家成功样本；对小卖家来说，当前没有任何“<300评论/年”的真实成功证据，反而只有一个失败样本，且失败原因是不够差异化、竞争太挤、利润偏薄。
结论：大品牌也只是勉强有机会，小卖家不该进。 以你500000 CNY预算看，做单个ASIN在资金上不是问题，但这类成功更依赖品牌力、配方/功能差异和长期投放，预算表里也没有给出清晰的低门槛切入成本；换句话说，不是“钱够不够”，而是“就算花钱也未必赢”。如果硬要做，唯一应跟随的对象是Secret的盈利款B0FQKSWJN1，但这条路更像品牌战，不像小商家机会；B0FL5ZJ5QW则应直接避开。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0FQKSWJN1Secret2025-12-12Yes$16.671000pcs$16670.028.26%$4710.95Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0FQKSWJN1Secret2025-12-12Yes$16.671000pcs$16670.028.26%$4710.95#New Product Success Rates
Listing这不是一个值得进入的市场：当前样本里新产品成功率只有50%，但真正能代表新品牌的成功案例几乎只有 Secret 的 1 个盈利 ASIN（B0FQKSWJN1），另 1 个新产品 B0FL5ZJ5QW 直接亏损，说明市场对新进者并不友好，而且成功高度集中、可复制性很弱。 从产品特征看，盈利款依赖“品牌力+旧款延伸+功能升级”，不是小品牌靠简单改款就能轻松复制；而亏损款则暴露出“相似度太高、缺乏差异化、竞争极强”的典型死局。
证据很直接：Secret 作为新进入品牌，品牌层面成功率 50%，但样本只有 2 个产品，统计力度很弱；更关键的是，盈利款 B0FQKSWJN1 月收入约 16,670 美元，售价 16.67 美元，靠的是 100 小时止汗、3X 压力汗防护、透明质酸与 pH 平衡配方等功能强化，属于需要更高研发和品牌包装投入的路线，而不是低预算可复制路线。 亏损款 B0FL5ZJ5QW 的失败原因明确是“不够独特 + 市场太小/竞争太激烈 + 利润空间本来就低”；这类产品不是小企业能靠正常打法打赢的。你当前预算 50 万 CNY 虽然看起来不低，但工具显示该类新产品的建议预算没有给出可直接落地的低门槛区间，同时系统也提示低于 2 万美元的启动通常容易失败，而这条赛道还可能额外吃掉 R&D、品牌与合规成本。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
SecretNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Secret#Success Rate by Entry Time
Listing这个市场不值得进入，属于高风险但不是真正的规模化机会。 目前样本里只有 2 个新发布产品，成功率 50%，表面上不差，但市场样本太小，不能说明竞争友好；更关键的是，已出现 500000 CNY 级别预算才可能做起来的案例，说明不是轻投入市场。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 1 0 0 1 2026 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 1 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 1 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesSecret Clinical Strength 100HR Sweat & Odor, Invisible Solid Antiperspirant Deodorant for Women, Free & Sensitive, 3X Stress Protection with Hyaluronic Acid, PH Balanced, Unscented, 2.6 oz
This listing is deemed profitablePrice (USD)$16.67Released TypeNew Release (2025-12-12)Brand is a new entry in this marketSize and Weight14.9 x 6.9 x 4.2 cm, 73.00gProfitable Factors
Established brand with longevityBased on old ASINDistinct functions and featuresDesign & Appearance
包装以浅蓝+白色为主，呈现清爽、专业的临床护理感, 无明显私模结构，更像标准旋转式固体止汗剂；差异主要来自临床版包装信息与规格表达Key Buying Motive
100小时止汗除臭、3X压力汗防护、含透明质酸与pH平衡配方，主打敏感肌可用Target Customers
针对需要强效止汗、但又希望配方更温和、减少白痕和刺激的女性用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$16,670.001000 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight26.38% / 28.26%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight24.24% / 26.13%Peak / Non PeakSales & BSR Performance